All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
LevFinLevFin High Yield Bonds

Stada slips out €200m, trumpets lack of coronavirus impact

pills adobe stock 575x375 pharmaceuticals

Pharmaceutical company Stada announced a €200m bond on Tuesday, a "mirror" of its existing 3.5% 2024s. The new issue is rated B2 at Moody’s, making it one of the lowest rated issues to have surfaced in euro high yield since the coronavirus crisis hit, but Stada is one of the least affected issuers in the market, and said that March 2020 saw its highest ever monthly production.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree